TCL Archive ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards? November 8, 2002
TCL Archive Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86 February 6, 1987
TCL Archive NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation June 12, 1992